Onyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
EMERYVILLE, CALIF. — Apr. 28, 2005
Contact:
Julie Wood
510-597-6505
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Morgan Stanley Global Healthcare Unplugged conference on Wednesday, May 4, at 2:15 p.m. Eastern Time.
Interested parties may access a live webcast of the presentation at:
http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ONXX&item_id=1044882
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through June 3, 2005.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including sorafenib with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at www.onyx-pharm.com.
Back to 2005 Press Releases
